logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Genetic Influences On Response To Drug Treatment For Major Psychiatric Disorders 1st Edition Janusz K Rybakowski

  • SKU: BELL-5355266
Genetic Influences On Response To Drug Treatment For Major Psychiatric Disorders 1st Edition Janusz K Rybakowski
$ 31.00 $ 45.00 (-31%)

4.3

38 reviews

Genetic Influences On Response To Drug Treatment For Major Psychiatric Disorders 1st Edition Janusz K Rybakowski instant download after payment.

Publisher: ADIS
File Extension: PDF
File size: 1.65 MB
Pages: 125
Author: Janusz K. Rybakowski, Alessandro Serretti (eds.)
ISBN: 9783319270388, 9783319270401, 3319270389, 3319270400
Language: English
Year: 2016
Edition: 1

Product desciption

Genetic Influences On Response To Drug Treatment For Major Psychiatric Disorders 1st Edition Janusz K Rybakowski by Janusz K. Rybakowski, Alessandro Serretti (eds.) 9783319270388, 9783319270401, 3319270389, 3319270400 instant download after payment.

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.

Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.

Related Products